Examination of efficacy and safety of new 5-ASA preparation for ulcerative colitis, and new method of evaluating disease condition by measuring fecal concentration of calprotectin.
Not Applicable
Recruiting
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000005823
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients without agreement of this study (2)Pregnant women and women suspected of being pregnant (3)Patients with history of total or partial colectomy operation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method non-relapse rate by CAI score after three months
- Secondary Outcome Measures
Name Time Method Clinical Activity Index Patient Diary Non-relapse rate after 1,2,3 months Inflammatory response score (WBC,Plt, ESR, CRP) Safety Remission period (month)